New legislation has been introduced in the U.S. House of Representatives that, if signed into law, would improve patient access to critical cardiac and pulmonary rehabilitation (CR/PR) programs under Medicare. The Increasing Access to Quality Cardiac Rehabilitation Care Act of 2021 (HR 1956) was introduced by Rep. Lisa Blunt Rochester, a Democrat out of Delaware, and Rep. Adrian Smith, a Republican out of Nebraska.

The bill would allow advanced practice providers such as physician assistants and nurse practitioners to supervise day-to-day rehabilitation in 2022 instead of 2024, when that change is currently scheduled to go into effect.

“Heart disease is a leading cause of death in Delaware, but we know that reducing barriers to accessing cardiac rehabilitation has direct patient benefits, including the risk of a future cardiac event,” Blunt Rochester said in a statement.

“Nebraskans from all parts of the state are affected by heart and lung disease and need access to cardiac and pulmonary rehabilitation programs, which are proven to enhance patients’ health and quality of life,” Smith added. “This legislation will increase access for cardiac patients, particularly in rural areas, by expanding who can order and supervise these programs, ensuring patients receive the care they need.”

The American College of Cardiology (ACC) and American Heart Association (AHA) both came out in support of the legislation after it was introduced.

“Every day in my practice I work with advanced practice providers who are routinely on the front line in critical care environments and who are highly trained and qualified to provide these safe, effective and vital services,” Samuel Jones IV, MD, chair of the ACC’s health affairs committee, said in a statement. “Passage of this critical legislation will go a long way toward eliminating unnecessary obstacles and delays to this life changing–and life-saving therapy, especially in rural and underserved communities.”

“This legislation would bridge the gap between referral and the start of CR/PR and help Medicare patients more equitably access proven services to help improve their health outcomes,” Nancy Brown, AHA CEO, said in a separate statement. “We strongly urge passage of this vital legislation during the 117th Congress.”



Disease Condition ,Therapeutic Modality ,Risk factors-comorbidities,Coronary Artery Disease,Cardiovascular diabetes,Congenital Heart Disease,Heart Failure,Hypertension,Valvular heart disease,Arrhythmias,Myocardial Disease and Cardiomyopathies,Pericardial Disease,Peripheral vascular diseases,Pulmonary disorders,Cardiac rehabillitation,Metabolic and Mixed disorders,Acute Coronary Syndrome,Angina Pectoris,Cardiac Syndrome X,Coronary Artery Vasospasm,Myocardial Infarction,STEMI,Ischemic Heart Disease,DCAD_others,Diabetes and Heart disorders,DCDM_Others,Aortic Coarctation,Atrial Septal Defect,ventricular septal defect,Congenitally Corrected Transposition,Cor Triatriatum,Ebstein Anomaly,Eisenmenger Syndrome,Endocardial Cushion Defects,Holt-Oram Syndrome,Isolated Coronary Artery Anomalies,Lutembacher Syndrome,Patent Foramen Ovale,Sinus of Valsalva Aneurysm,Tetralogy of Fallot,Tricuspid Atresia,Wolff-Parkinson-White Syndrome,DCHD_Others,DHTF_Others,Hypotension,DHTN_others,Aortic Regurgitation,Aortic Stenosis,Infective Endocarditis,Libman-Sacks Endocarditis,Loeffler Endocarditis,Mitral Annular Calcification,Mitral Regurgitation,Mitral Stenosis,Mitral Valve Prolapse,Prosthetic Heart Valves,Pulmonic Regurgitation,Pulmonic Stenosis,Pulmonic Valvular Stenosis,Rheumatic Fever,Supravalvular Ring Mitral Stenosis,Tricuspid Regurgitation,Tricuspid Stenosis,DVHD_Others,Accelerated Idioventricular Rhythm,Antidysrhythmic Toxicity,Arrhythmogenic Right Ventricular Dysplasia (ARVD),Ashman Phenomenon,Asystole,Atrial Fibrillation,Atrial Flutter,Atrial Tachycardia,Atrioventricular Block,Atrioventricular Dissociation,Atrioventricular Nodal Reentry Tachycardia,Brugada Syndrome,Cardiac Resynchronization Therapy,Digitalis Toxicity,Electrical Alternans,First-Degree Atrioventricular Block,Holiday Heart Syndrome,Junctional Rhythm,Long QT Syndrome,Lown-Ganong-Levine Syndrome,Multifocal Atrial Tachycardia,Pacemaker-Mediated Tachycardia,Paroxysmal Supraventricular Tachycardia,Premature Ventricular Contraction,Pulseless Electrical Activity,Second-Degree Atrioventricular Block,Sinus Bradycardia,Sinus Node Dysfunction,Sudden Cardiac Death,Third-Degree Atrioventricular Block,Torsade de Pointes,Ventricular Fibrillation,Ventricular Premature Complexes,Ventricular Tachycardia,DARR_others,Alcoholic Cardiomyopathy,Cardiac Cirrhosis ,Cardiogenic Pulmonary Edema,Cardiogenic Shock,Cocaine-Related Cardiomyopathy,Cor Pulmonale,Dilated Cardiomyopathy,Endomyocardial Fibrosis,Hypertrophic Cardiomyopathy,Myocardial Abscess,Myocarditis,Myopathies,Viral Myocarditis,Peripartum Cardiomyopathy,Restrictive Cardiomyopathy,Takotsubo Cardiomyopathy,Myocardial Rupture,syncope,DCMP_others,Acute Pericarditis,Cardiac Tamponade,Constrictive Pericarditis,Effusive-Constrictive Pericarditis,Pericardial Effusion,Postpericardiotomy Syndrome,DPCD_others,Aortic Dissection,Carotid Artery Dissection,Deep Venous Thrombosis,Peripheral Vascular Disease,Subclavian Artery Thrombosis,Subclavian Vein Thrombosis,Takayasu Arteritis,Thoracic Aneurysm,Thoracic Aortic Aneurysm,Vertebral Artery Dissection,Aortitis,Vasculitis,Fibromuscular Dysplasia,Popliteal Artery Entrapment Syndrome,Acute Limb Ischemia,Atheroembolism,Carotid Sinus Hypersensitivity,PVD_others,Pulmonary Embolism,Pulmonary Hypertension ,DOUL_others,Cardiac Rehab,TRHB_others